TGF-BETA SIGNALING IN ENDOMETRIAL CELL FUNCTION AND DYSFUNCTION

子宫内膜细胞功能和功能障碍中的 TGF-β 信号传导

基本信息

  • 批准号:
    10112273
  • 负责人:
  • 金额:
    $ 29.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-03-01 至 2023-02-28
  • 项目状态:
    已结题

项目摘要

Title: TGF-BETA SIGNALING IN ENDOMETRIAL CELL FUNCTION AND DYSFUNCTION Project Summary/Abstract An increasing number of reproductive-aged women face pregnancy loss and infertility, some of which is associated with endometrial dysfunction. A lack of understanding of mechanisms governing endometrial development and function prevents an effective treatment for such disorders. Therefore, there is a critical need to define the mechanisms underlying endometrial cell proliferation, differentiation, and function. Research on human endometrial function during pregnancy remains challenging due to ethical constrains on the access to tissue specimens, making the mouse model particularly valuable. Transforming growth factor β (TGFβ) superfamily signaling regulates fundamental cellular functions and developmental processes in reproductive organs including the uterus. The in vivo function of TGFβ signaling in uterine biology remains poorly understood due to the redundancy of TGFβ ligands and lack of appropriate animal models. By genetically manipulating TGFβ type 1 receptor (TGFBR1) using both loss-of-function and gain-of-function mouse models, we have discovered that TGFβ signaling is required for fertility and female reproductive tract development. Guided by our compelling preliminary findings, the overall objective in this R01 proposal is to decipher the cellular, molecular, and epigenetic mechanisms underpinning endometrial cell proliferation, differentiation, and function. Our central hypothesis is that endometrial cell properties and function are regulated by a well-balanced TGFβ signaling system essential for uterine development and pregnancy. We will test our hypothesis by pursuing the following two specific aims: 1) Define how TGFβ signaling regulates endometrial epithelial cell proliferation during uterine development. 2) Identify the role and associated mechanism of TGFβ signaling in endometrial stromal cell function and dysfunction during pregnancy. The proposed research is innovative because it involves the use of unique and complementary novel mouse models to decipher the role and associated mechanisms of TGFβ signaling in endometrial cells, the application of uterine epithelial and stromal cell culture and co-culture system to uncover how TGFβ signaling regulates stromal-epithelial interaction, a key but poorly defined event in uterine development and function, and the identification of TGFBR1-dependent epigenetic mechanisms in endometrial stromal cells. Studies proposed in this application represent the next step in a continuum of research toward the development of targeted interventions for endometrial dysfunction and pregnancy complications. Thus, completion of this proposal is expected to provide a new paradigm for understanding the mechanisms of endometrial dysfunction, and provide a rational basis for future research that focuses on testing the translational potential of targeting TGFβ signaling cascade in the treatment of endometrial dysfunction.
Title: TGF-BETA SIGNALING IN ENDOMETRIAL CELL FUNCTION AND DYSFUNCTION Project Summary/Abstract An increasing number of reproductive-aged women face pregnancy loss and infertility, some of which is associated with endometrial dysfunction. A lack of understanding of mechanisms governing endometrial development and function prevents an effective treatment for such disorders. Therefore, there is a critical need to define the mechanisms underlying endometrial cell proliferation, differentiation, and function. Research on human endometrial function during pregnancy remains challenging due to ethical constrains on the access to tissue specimens, making the mouse model particularly valuable. Transforming growth factor β (TGFβ) superfamily signaling regulates fundamental cellular functions and developmental processes in reproductive organs including the uterus. The in vivo function of TGFβ signaling in uterine biology remains poorly understood due to the redundancy of TGFβ ligands and lack of appropriate animal models. By genetically manipulating TGFβ type 1 receptor (TGFBR1) using both loss-of-function and gain-of-function mouse models, we have discovered that TGFβ signaling is required for fertility and female reproductive tract development. Guided by our compelling preliminary findings, the overall objective in this R01 proposal is to decipher the cellular, molecular, and epigenetic mechanisms underpinning endometrial cell proliferation, differentiation, and function. Our central hypothesis is that endometrial cell properties and function are regulated by a well-balanced TGFβ signaling system essential for uterine development and pregnancy. We will test our hypothesis by pursuing the following two specific aims: 1) Define how TGFβ signaling regulates endometrial epithelial cell proliferation during uterine development. 2) Identify the role and associated mechanism of TGFβ signaling in endometrial stromal cell function and dysfunction during pregnancy. The proposed research is innovative because it involves the use of unique and complementary novel mouse models to decipher the role and associated mechanisms of TGFβ signaling in endometrial cells, the application of uterine epithelial and stromal cell culture and co-culture system to uncover how TGFβ signaling regulates stromal-epithelial interaction, a key but poorly defined event in uterine development and function, and the identification of TGFBR1-dependent epigenetic mechanisms in endometrial stromal cells. Studies proposed in this application represent the next step in a continuum of research toward the development of targeted interventions for endometrial dysfunction and pregnancy complications. Thus, completion of this proposal is expected to provide a new paradigm for understanding the mechanisms of endometrial dysfunction, and provide a rational basis for future research that focuses on testing the translational potential of targeting TGFβ signaling cascade in the treatment of endometrial dysfunction.

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
TGFβ superfamily signaling and uterine decidualization.
Role of EZH2 in Uterine Gland Development.
Functional similarity between TGF-beta type 2 and type 1 receptors in the female reproductive tract.
  • DOI:
    10.1038/s41598-021-88673-y
  • 发表时间:
    2021-04-29
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Ni N;Fang X;Li Q
  • 通讯作者:
    Li Q
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Qinglei Li其他文献

Qinglei Li的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Qinglei Li', 18)}}的其他基金

UTX: A novel regulator of decidualization?
UTX:蜕膜化的新型调节剂?
  • 批准号:
    10390537
  • 财政年份:
    2022
  • 资助金额:
    $ 29.77万
  • 项目类别:
UTX: A novel regulator of decidualization?
UTX:蜕膜化的新型调节剂?
  • 批准号:
    10570990
  • 财政年份:
    2022
  • 资助金额:
    $ 29.77万
  • 项目类别:
A novel mouse model of testicular granulosa cell tumors
一种新型小鼠睾丸颗粒细胞瘤模型
  • 批准号:
    10062490
  • 财政年份:
    2019
  • 资助金额:
    $ 29.77万
  • 项目类别:
TGF-BETA SIGNALING IN ENDOMETRIAL CELL FUNCTION AND DYSFUNCTION
子宫内膜细胞功能和功能障碍中的 TGF-β 信号传导
  • 批准号:
    9886078
  • 财政年份:
    2017
  • 资助金额:
    $ 29.77万
  • 项目类别:
Characterization of a novel mouse model with enhanced TGF-Beta signaling in the ovary
卵巢中 TGF-Beta 信号传导增强的新型小鼠模型的表征
  • 批准号:
    8968721
  • 财政年份:
    2015
  • 资助金额:
    $ 29.77万
  • 项目类别:
TGF-BETA Signaling in Myometrial Development and Function
子宫肌层发育和功能中的 TGF-BETA 信号传导
  • 批准号:
    8358471
  • 财政年份:
    2012
  • 资助金额:
    $ 29.77万
  • 项目类别:
TGF-BETA Signaling in Myometrial Development and Function
子宫肌层发育和功能中的 TGF-BETA 信号传导
  • 批准号:
    8523949
  • 财政年份:
    2012
  • 资助金额:
    $ 29.77万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Enhancing apoptosis of cancers using systems biology approach
使用系统生物学方法增强癌症细胞凋亡
  • 批准号:
    25430184
  • 财政年份:
    2013
  • 资助金额:
    $ 29.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of cellular Inhibitors of Apoptosis (cIAPs) in muscle biology and disease
细胞凋亡抑制剂 (cIAP) 在肌肉生物学和疾病中的作用
  • 批准号:
    267331
  • 财政年份:
    2012
  • 资助金额:
    $ 29.77万
  • 项目类别:
    Operating Grants
Apoptosis in Biochemistry and Structural Biology
生物化学和结构生物学中的细胞凋亡
  • 批准号:
    6742311
  • 财政年份:
    2004
  • 资助金额:
    $ 29.77万
  • 项目类别:
Death receptors in prostate cancer biology and apoptosis
前列腺癌生物学和细胞凋亡中的死亡受体
  • 批准号:
    6514803
  • 财政年份:
    2001
  • 资助金额:
    $ 29.77万
  • 项目类别:
Biology and Regulation of inhibitor of apoptosis proteins - IAPs
凋亡蛋白抑制剂 - IAP 的生物学和调控
  • 批准号:
    nhmrc : 7187
  • 财政年份:
    2001
  • 资助金额:
    $ 29.77万
  • 项目类别:
    Early Career Fellowships
Death receptors in prostate cancer biology and apoptosis
前列腺癌生物学和细胞凋亡中的死亡受体
  • 批准号:
    6384220
  • 财政年份:
    2001
  • 资助金额:
    $ 29.77万
  • 项目类别:
MOLECULAR BIOLOGY OF SALIVARY ACINAR CELL APOPTOSIS
唾液腺泡细胞凋亡的分子生物学
  • 批准号:
    2749388
  • 财政年份:
    1997
  • 资助金额:
    $ 29.77万
  • 项目类别:
MOLECULAR BIOLOGY OF APOPTOSIS IN IRRADIATED NEURONS
受辐射神经元细胞凋亡的分子生物学
  • 批准号:
    2546420
  • 财政年份:
    1997
  • 资助金额:
    $ 29.77万
  • 项目类别:
MOLECULAR BIOLOGY OF APOPTOSIS IN IRRADIATED NEURONS
受辐射神经元细胞凋亡的分子生物学
  • 批准号:
    2036849
  • 财政年份:
    1997
  • 资助金额:
    $ 29.77万
  • 项目类别:
MOLECULAR BIOLOGY OF SALIVARY ACINAR CELL APOPTOSIS
唾液腺泡细胞凋亡的分子生物学
  • 批准号:
    2407897
  • 财政年份:
    1997
  • 资助金额:
    $ 29.77万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了